IFP Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $450 | Sell |
31
-34
| -52% | -$395 | ﹤0.01% | 4444 |
|
|
2025
Q4 | $625 | Buy |
65
+42
| +183% | +$402 | ﹤0.01% | 4221 |
|
|
2025
Q3 | $216 | Buy |
+23
| New | +$220 | ﹤0.01% | 4382 |
|
|
2025
Q2 | – | Sell |
-4
| Closed | -$50 | – | 4725 |
|
|
2025
Q1 | $60 | Hold |
4
| – | – | ﹤0.01% | 3983 |
|
|
2024
Q4 | $66 | Buy |
+4
| New | +$79 | ﹤0.01% | 4167 |
|
|
2023
Q1 | – | Sell |
-17
| Closed | -$3K | – | 3395 |
|
|
2022
Q4 | $3K | Buy |
+17
| New | +$484 | ﹤0.01% | 3972 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3425 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3113 |
|
|
2021
Q1 | – | Sell |
-37
| Closed | -$1.4K | – | 3061 |
|
|
2020
Q4 | $2K | Buy |
+37
| New | +$1.4K | ﹤0.01% | 2582 |
|
|
2018
Q2 | – | Sell |
-225
| Closed | -$12K | – | 3862 |
|
|
2018
Q1 | $12K | Hold |
225
| – | – | ﹤0.01% | 2659 |
|
|
2017
Q4 | $12K | Hold |
225
| – | – | ﹤0.01% | 2696 |
|
|
2017
Q3 | $13K | Buy |
+225
| New | +$11.8K | ﹤0.01% | 2864 |
|
|
2017
Q1 | – | Sell |
-740
| Closed | -$36K | – | 3976 |
|
|
2016
Q4 | $36K | Buy |
740
+40
| +6% | +$1.85K | ﹤0.01% | 2067 |
|
|
2016
Q3 | $33K | Sell |
700
-440
| -39% | -$21.7K | ﹤0.01% | 2069 |
|
|
2016
Q2 | $61K | Buy |
+1,140
| New | +$53.7K | ﹤0.01% | 1648 |
|
|
2016
Q1 | – | Sell |
-20
| Closed | -$1K | – | 2397 |
|
|
2015
Q4 | $1K | Buy |
+20
| New | +$765 | ﹤0.01% | 3473 |
|
Other funds holding ANIK
CP
VCM
BFM
CM
